Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
$8.15
+0.7%
$8.56
$2.18
$11.12
$87.65M0.9829,952 shs5,518 shs
LifeMD, Inc. stock logo
LFMD
LifeMD
$6.35
-1.3%
$6.38
$3.99
$15.84
$300.88M1.671.56 million shs696,308 shs
KindlyMD, Inc. stock logo
NAKA
KindlyMD
$0.77
-3.6%
$4.89
$0.65
$34.77
$318.80M31.17.16 million shs17.15 million shs
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
$3.85
-4.1%
$3.58
$0.13
$4.50
$358.57M0.081.51 million shs1.95 million shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
-4.71%-9.10%-7.12%+75.49%+179.93%
LifeMD, Inc. stock logo
LFMD
LifeMD
+1.26%-3.16%+10.29%-42.07%+33.40%
KindlyMD, Inc. stock logo
NAKA
KindlyMD
+1.29%-16.69%-35.49%-93.00%+79,989,900.00%
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
+0.50%+1.01%+28.53%+9.86%+1,149.61%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
$8.15
+0.7%
$8.56
$2.18
$11.12
$87.65M0.9829,952 shs5,518 shs
LifeMD, Inc. stock logo
LFMD
LifeMD
$6.35
-1.3%
$6.38
$3.99
$15.84
$300.88M1.671.56 million shs696,308 shs
KindlyMD, Inc. stock logo
NAKA
KindlyMD
$0.77
-3.6%
$4.89
$0.65
$34.77
$318.80M31.17.16 million shs17.15 million shs
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
$3.85
-4.1%
$3.58
$0.13
$4.50
$358.57M0.081.51 million shs1.95 million shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
-4.71%-9.10%-7.12%+75.49%+179.93%
LifeMD, Inc. stock logo
LFMD
LifeMD
+1.26%-3.16%+10.29%-42.07%+33.40%
KindlyMD, Inc. stock logo
NAKA
KindlyMD
+1.29%-16.69%-35.49%-93.00%+79,989,900.00%
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
+0.50%+1.01%+28.53%+9.86%+1,149.61%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
1.00
SellN/AN/A
LifeMD, Inc. stock logo
LFMD
LifeMD
2.67
Moderate Buy$13.17108.33% Upside
KindlyMD, Inc. stock logo
NAKA
KindlyMD
2.33
Hold$5.00539.96% Upside
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
2.75
Moderate Buy$7.0072.20% Upside

Current Analyst Ratings Breakdown

Latest BNR, NAKA, TOI, and LFMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/15/2025
KindlyMD, Inc. stock logo
NAKA
KindlyMD
B. Riley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$2.00
10/8/2025
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
10/8/2025
LifeMD, Inc. stock logo
LFMD
LifeMD
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
10/8/2025
KindlyMD, Inc. stock logo
NAKA
KindlyMD
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
10/8/2025
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
9/27/2025
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
9/27/2025
LifeMD, Inc. stock logo
LFMD
LifeMD
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
9/27/2025
KindlyMD, Inc. stock logo
NAKA
KindlyMD
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
9/27/2025
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
9/5/2025
LifeMD, Inc. stock logo
LFMD
LifeMD
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong SellHold
9/3/2025
KindlyMD, Inc. stock logo
NAKA
KindlyMD
Maxim Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$8.00
(Data available from 10/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
$536.30M0.17N/AN/A$7.39 per share1.11
LifeMD, Inc. stock logo
LFMD
LifeMD
$212.45M1.41N/AN/A($0.09) per share-70.22
KindlyMD, Inc. stock logo
NAKA
KindlyMD
$2.72M118.80N/AN/A$0.43 per share1.82
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
$393.41M0.97N/AN/A$0.05 per share81.30
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
-$47.49M-$1.90N/AN/A-26.04%-23.61%-15.73%12/2/2025 (Estimated)
LifeMD, Inc. stock logo
LFMD
LifeMD
-$18.88M-$0.21N/A52.67N/A-2.41%N/A-8.11%11/6/2025 (Estimated)
KindlyMD, Inc. stock logo
NAKA
KindlyMD
-$3.62M-$0.86N/AN/A-244.00%-131.09%-106.04%N/A
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
-$64.66M-$0.68N/AN/A-14.26%-1,527.21%-34.25%11/12/2025 (Estimated)

Latest BNR, NAKA, TOI, and LFMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/12/2025Q3 2025
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
-$0.12N/AN/AN/A$122.63 millionN/A
11/6/2025Q3 2025
LifeMD, Inc. stock logo
LFMD
LifeMD
-$0.06N/AN/AN/A$62.07 millionN/A
9/8/2025Q2 2025
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
N/A-$0.15N/A-$0.15N/A$20.74 million
8/5/2025Q2 2025
KindlyMD, Inc. stock logo
NAKA
KindlyMD
N/A-$0.34N/A-$0.35N/A$0.41 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
N/AN/AN/AN/AN/A
LifeMD, Inc. stock logo
LFMD
LifeMD
N/AN/AN/AN/AN/A
KindlyMD, Inc. stock logo
NAKA
KindlyMD
N/AN/AN/AN/AN/A
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
N/A
3.22
2.97
LifeMD, Inc. stock logo
LFMD
LifeMD
9.21
0.77
0.72
KindlyMD, Inc. stock logo
NAKA
KindlyMD
N/A
13.00
13.00
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
14.58
1.62
1.37

Institutional Ownership

CompanyInstitutional Ownership
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
30.03%
LifeMD, Inc. stock logo
LFMD
LifeMD
35.52%
KindlyMD, Inc. stock logo
NAKA
KindlyMD
N/A
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
36.86%

Insider Ownership

CompanyInsider Ownership
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
30.30%
LifeMD, Inc. stock logo
LFMD
LifeMD
18.40%
KindlyMD, Inc. stock logo
NAKA
KindlyMD
40.79%
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
8.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
1,39010.76 million7.50 millionNot Optionable
LifeMD, Inc. stock logo
LFMD
LifeMD
23047.42 million38.69 millionOptionable
KindlyMD, Inc. stock logo
NAKA
KindlyMD
N/A413.60 million244.89 millionN/A
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
66093.50 million85.56 millionNot Optionable

Recent News About These Companies

Topicus: Rising To The Topicus Of VMS Supremacy In Europe
The Oncology Institute Q2 Revenue Surges

New MarketBeat Followers Over Time

Media Sentiment Over Time

Burning Rock Biotech stock logo

Burning Rock Biotech NASDAQ:BNR

$8.14 +0.06 (+0.68%)
As of 03:41 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Burning Rock Biotech Limited primarily develops and commercializes cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based tissue and liquid biopsy cancer therapy selection and prognosis prediction tests for various range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its principal products include OncoCompass IO, a corresponding test for liquid biopsy samples; OncoScreen IO, a pan-cancer test for tissue samples; and OncoCompass Target, a ctDNA liquid biopsy-based test for NSCLC. In addition, the company provides ColonCore for assessing microsatellite loci related to MSI status and detecting mutations in genes associated with gastrointestinal cancers; and brPROPHET, a pre-operative ctDNA detection and post-operative MRD calling for relapsed patients. Further, it has development and commercialization agreement with Myriad Genetics, Inc. to in-license Myriad myChoice tumor testing in China; licensing agreement with Oncocyte Corporation to in-license DetermaRx, a risk stratification test for early stage lung cancer patients in China; and collaborations on clinical trials and research studies with AstraZeneca, Bayer, Johnson & Johnson, CStone, BeiGene, Abbisko Therapeutics, and IMPACT Therapeutics and Merck KGaA. Additionally, the company offers OncoMaster, an automatic NGS data analysis and report interpretation machine for in-hospital model. Burning Rock Biotech Limited was incorporated in 2014 and is headquartered in Guangzhou, China.

LifeMD stock logo

LifeMD NASDAQ:LFMD

$6.34 -0.09 (-1.32%)
As of 03:46 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

KindlyMD stock logo

KindlyMD NASDAQ:NAKA

$0.77 -0.03 (-3.64%)
As of 03:27 PM Eastern

Kindly MD, Inc. (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, medically managed weight loss, and hormone therapy. Through its focus on an embedded model of prescriber and therapist teams, KindlyMD develops patient-specific care programs with a specific mission to reduce opioid use in the patient population while successfully treating patients with effective and evidence-based non-opioid alternatives in close conjunction with behavioral therapy. Beyond its treatment of patients, KindlyMD collects data focused on why and how patients turn to alternative treatments to reduce prescription medication use and addiction. The Company captures all relevant datapoints to assist and appropriately treat each individual patient. This also results in valuable data for the Company and the Company’s investors. We strive to become a source for evidence-based guidelines, data, treatment models, and education in the fight against the opioid crisis in America. Business Revenue Streams We currently earn revenue through (i) patient care services related to medical evaluation and treatment and (ii) product retail sales. Our forecasted plan is to operate across various revenue streams: (i) medical evaluation and treatment visits reimbursed by Medicare, Medicaid, and commercial insurance payers as well as self-pay services, (ii) data collection and research, (iii) education partnerships, (iv) service affiliate agreements, and (v) retail sales. Our principal executive offices are located at 5097 S 900 E, Suite 100 Salt Lake City, UT.

Oncology Institute stock logo

Oncology Institute NASDAQ:TOI

$3.84 -0.17 (-4.11%)
As of 03:45 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.